Official UK procurement notice
NHS London Branded Medicines - Tranche B - September 2023
Authority: NHS England (Central government)
What is being bought2 lots · detail below
Published requirement descriptionProject Title: NHS London Branded Medicines - Tranche B - September 2023<br/><br/>Offer reference number: CM/PHR/22/5677<br/><br/>CM/PHR/22/5677/01 - NHS Framework for London Branded Medicines - Tranche B. Period of framework: 1 September 2023 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months<br/><br/>CM/PHR/22/5677/02 - NHS Framework for London Branded Medicines - Annual Tranche. Period of framework: 1 September 2023 to 31 August 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.
CPV: Pharmaceutical products
How this framework works
From the published notice- Bids received
- 25 bids on the busiest of 2 lots · 36 suppliers appointed
- Framework period
- 2 yrs from 1 Sept 2023
Lots and requirements (2)Procurement structure
2 lots · all with a published valueLot #1CM/PHR/22/5677/01 - NHS London Branded Medicines - Tranche B Lot 1AwardedPublished value£253,484,000
CM/PHR/22/5677/01 - NHS Framework for London Branded Medicines - Tranche B. Period of framework: 1 September 2023 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
Lot #2CM/PHR/22/5677/02 - NHS London Branded Medicines - Tranche B Lot 2AwardedPublished value£192,267,000
CM/PHR/22/5677/02 - NHS Framework for London Branded Medicines - Annual Tranche. Period of framework: 1 September 2023 to 31 August 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
- “NHS London Branded Medicines - Tranche B - September 2023” is a framework: the contest is a place on its panel, not a single contract.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 13 Mar 2023, 12:14 GMT
- Last source update
- 8 Aug 2023, 14:41 BST
- Award evaluation window
- 17 Apr 2023 – …
- Authority reference
CM/PHR/22/5677- FTS notice number
2023/S 000-023090- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-03b23bFind a Tender
- Electronic trading
- e-invoicing allowed · electronic ordering · electronic payment
Publisher note: RESPONDING TO THIS NOTICE;<br/>Any supplier may be disqualified who does not respond to the following in the requisite manner:<br/>1) Submission of expression of interest and procurement specific information. This procurement exercise will be conducted on the eTendering portal at http://health.atamis.co.uk<br/>Candidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested) through the eTendering portal as follows:<br/>1.1) If not already registered, Candidates should register on the eTendering portal at http://health.atamis.co.uk and click the link to register:<br/>- agree to the user agreement<br/>- populate company details<br/>1.2) Once registered, candidates must register interest as follows:<br/>- log to the portal<br/>- select "Find Opportunities" from the supplier home screen, use the "Sort by:" facility to find this opportunity and select the bold blue title to select<br/>- review opportunity details and click "Register Interest"<br/>- as you select the opportunity, you can review documents, send clarification messages, submit the response or decline to respond (if you decide not to participate in the opportunity)<br/>1.3) There is a supplier user guide on using the system and Candidates can contact the Atamis helpdesk at [email protected] or by calling 0800 9956035 for technical assistance when completing responses.<br/>2) General supplier information.<br/>To manage and assess supplier information the Contracting Authority requests candidates provide their<br/>company profile in the Government's Supplier Registration Service (which has replaced sid4gov), as follows:<br/>2.1) If not already registered (the previous sid4gov password, login and details will still<br/>be on the system), candidates must go to the following web page https://supplierregistration.cabinetoffice.gov.uk<br/>and select "Register" at the top of the page.<br/>Key in details as requested to search for your company. If you do not have a D-U-N-S® Number, click on the link at the right of the page to obtain a number from D&B.<br/>Candidates must obtain a Dun & Bradstreet (D&B) D-U-N-S® Number to enable registration on the system.<br/>2.2) Once registration is complete you are able to create and update your company profile. Candidates should ensure all the mandatory fields of their profile are completed and up to date for each procurement exercise.<br/>D&B data will be supplied automatically by D&B.<br/>2.3) For further help or information concerning this telephone +44 (0) 161 413 7982 or via the<br/>message function on the website.<br/>OTHER CONTRACTING AUTHORITIES<br/>The framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services.
How it was run
Official noticeTender documents are also served through a separate tool: https://health-family.force.com/s/Welcome ↗
- Appointment period ends
- 17 Apr 2023, 13:00 BST
- Submission channel
- {"electronicSubmission","written"}
- Accepted languages
- en
- Bids opened
- 17 Apr 2023, 13:00 BST
Timeline
17 Apr 2023 → 1 Sept 2023 · 5 dates- Admission / appointment period endsperiod end, not a bid countdown17 Apr 2023, 13:00 BST
- Bids opened17 Apr 2023, 13:00 BST
- Bids must remain valid until16 Jul 2023, 23:59 BST
- Notice published8 Aug 2023, 14:41 BST
- Contract starts1 Sept 2023, 00:00 BST
Notice history
1 event · 2 releases on Find a Tender- Status changed to complete8 Aug 2023, 14:41 BST
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast46 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
All 20 of these contracts carry the same published figure, £1, the framework's maximum for the whole notice, not each contract's own value. They are not eleven separate sums.
Lot 1 - CM/PHR/22/5677/01 - NHS Framework for London Branded Medicines - Tranche B
- Signed
- 14 Jul 2023
- Value
- ceiling above
- Period
- … – 31 Aug 2025
- Status
- active
Lot 1 - CM/PHR/22/5677/01 - NHS Framework for London Branded Medicines - Tranche B
- Signed
- 14 Jul 2023
- Value
- ceiling above
- Period
- … – 31 Aug 2025
- Status
- active
Lot 1 - CM/PHR/22/5677/01 - NHS Framework for London Branded Medicines - Tranche B
- Signed
- 14 Jul 2023
- Value
- ceiling above
- Period
- … – 31 Aug 2025
- Status
- active
Lot 1 - CM/PHR/22/5677/01 - NHS Framework for London Branded Medicines - Tranche B
- Signed
- 14 Jul 2023
- Value
- ceiling above
- Period
- … – 31 Aug 2025
- Status
- active
Lot 1 - CM/PHR/22/5677/01 - NHS Framework for London Branded Medicines - Tranche B
- Signed
- 14 Jul 2023
- Value
- ceiling above
- Period
- … – 31 Aug 2025
- Status
- active
Lot 1 - CM/PHR/22/5677/01 - NHS Framework for London Branded Medicines - Tranche B
- Signed
- 14 Jul 2023
- Value
- ceiling above
- Period
- … – 31 Aug 2025
- Status
- active
Lot 1 - CM/PHR/22/5677/01 - NHS Framework for London Branded Medicines - Tranche B
- Signed
- 14 Jul 2023
- Value
- ceiling above
- Period
- … – 31 Aug 2025
- Status
- active
Lot 1 - CM/PHR/22/5677/01 - NHS Framework for London Branded Medicines - Tranche B
- Signed
- 14 Jul 2023
- Value
- ceiling above
- Period
- … – 31 Aug 2025
- Status
- active
Lot 1 - CM/PHR/22/5677/01 - NHS Framework for London Branded Medicines - Tranche B
- Signed
- 14 Jul 2023
- Value
- ceiling above
- Period
- … – 31 Aug 2025
- Status
- active
Lot 1 - CM/PHR/22/5677/01 - NHS Framework for London Branded Medicines - Tranche B
- Signed
- 14 Jul 2023
- Value
- ceiling above
- Period
- … – 31 Aug 2025
- Status
- active
Lot 1 - CM/PHR/22/5677/01 - NHS Framework for London Branded Medicines - Tranche B
- Signed
- 14 Jul 2023
- Value
- ceiling above
- Period
- … – 31 Aug 2025
- Status
- active
Lot 1 - CM/PHR/22/5677/01 - NHS Framework for London Branded Medicines - Tranche B
- Signed
- 14 Jul 2023
- Value
- ceiling above
- Period
- … – 31 Aug 2025
- Status
- active
Lot 1 - CM/PHR/22/5677/01 - NHS Framework for London Branded Medicines - Tranche B
- Signed
- 14 Jul 2023
- Value
- ceiling above
- Period
- … – 31 Aug 2025
- Status
- active
Lot 1 - CM/PHR/22/5677/01 - NHS Framework for London Branded Medicines - Tranche B
- Signed
- 14 Jul 2023
- Value
- ceiling above
- Period
- … – 31 Aug 2025
- Status
- active
Lot 1 - CM/PHR/22/5677/01 - NHS Framework for London Branded Medicines - Tranche B
- Signed
- 14 Jul 2023
- Value
- ceiling above
- Period
- … – 31 Aug 2025
- Status
- active
Lot 1 - CM/PHR/22/5677/01 - NHS Framework for London Branded Medicines - Tranche B
- Signed
- 14 Jul 2023
- Value
- ceiling above
- Period
- … – 31 Aug 2025
- Status
- active
Lot 1 - CM/PHR/22/5677/01 - NHS Framework for London Branded Medicines - Tranche B
- Signed
- 14 Jul 2023
- Value
- ceiling above
- Period
- … – 31 Aug 2025
- Status
- active
Lot 2 - CM/PHR/22/5677/02 - NHS Framework for London Branded Medicines - Annual Tranche
- Signed
- 14 Jul 2023
- Value
- ceiling above
- Period
- … – 31 Aug 2024
- Status
- active
Lot 2 - CM/PHR/22/5677/02 - NHS Framework for London Branded Medicines - Annual Tranche
- Signed
- 14 Jul 2023
- Value
- ceiling above
- Period
- … – 31 Aug 2024
- Status
- active
Lot 2 - CM/PHR/22/5677/02 - NHS Framework for London Branded Medicines - Annual Tranche
- Signed
- 14 Jul 2023
- Value
- ceiling above
- Period
- … – 31 Aug 2024
- Status
- active
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| 1 · CM/PHR/22/5677/01 - NHS London Branded Medicines - Tranche B Lot 1 | 25bids · 25 electronic · 25 from abroad | 5 | — | — |
| 2 · CM/PHR/22/5677/02 - NHS London Branded Medicines - Tranche B Lot 2 | 22bids · 22 electronic · 22 from abroad | 3 | — | — |
Contracting authority & participating public bodies
Framework contractors & participating bidders
36 commercial parties on the notice- Abbvie LtdFramework contractor
- Accord-UK LtdFramework contractor
- AlmirallFramework contractor
- AstraZenecaFramework contractor
- Aventis Pharma ltd t/a SanofiFramework contractor
- Bayer PlcFramework contractor
- BiogenFramework contractor
- CST Pharma LimitedFramework contractor
- Celltrion Healthcare United Kingdom LimitedFramework contractor
- Eli Lilly and Company LtdFramework contractor
Show 26 more suppliers
- Galapagos Biotech UK LtdFramework contractor
- Gedeon Richter UK LtdFramework contractor
- Gilead Sciences LimitedFramework contractor
- GlaxoSmithKline UK LimitedFramework contractor
- IpsenFramework contractor
- Janssen-Cilag LtdFramework contractor
- Kent Pharma LtdFramework contractor
- Merck Serono LimitedFramework contractor
- Merck Sharpe and Dohme (UK) LimitedFramework contractor
- MylanFramework contractor
- Neon Healthcare LtdFramework contractor
- Novartis Pharmaceuticals UK LtdFramework contractor
- Novo NordiskFramework contractor
- Organon Pharmaceuticals UK LtdFramework contractor
- Orifarm UKFramework contractor
- Pfizer LtdFramework contractor
- Roche Products LtdFramework contractor
- Sandoz LtdFramework contractor
- Sobi (Swedish Orphan Biovitrum Ltd)Framework contractor
- Sun Pharma UK LtdFramework contractor
- Takeda UK LtdFramework contractor
- Teva UK LimitedFramework contractor
- Thornton and Ross LtdFramework contractor
- Typharm LtdFramework contractor
- UCB Pharma LtdFramework contractor
- Zentiva Pharma UK LtdFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.